R Nir-Paz
Overview
Explore the profile of R Nir-Paz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kviatkovski I, Yarnitzky T, Shushan S, Schwartz-Harari O, Nir-Paz R, Helman Y
Chem Commun (Camb)
. 2018 Aug;
54(66):9218-9221.
PMID: 30065984
2-Aminoacetophneone (2-AA) is a volatile molecule produced in high amounts by the opportunistic pathogen Pseudomonas aeruginosa. We have previously shown that 2-AA activates the quorum sensing (QS) LuxR receptor of...
2.
Dickstein Y, Nir-Paz R, Pulcini C, Cookson B, Beovic B, Tacconelli E, et al.
Clin Microbiol Infect
. 2016 Jul;
22(9):812.e9-812.e17.
PMID: 27373529
We aimed to assess the current status of infectious diseases (ID), clinical microbiology (CM) and infection control (IC) staffing in hospitals and to analyse modifiers of staffing levels. We conducted...
3.
Khoury T, Sviri S, Rmeileh A, Nubani A, Abutbul A, Hoss S, et al.
Clin Microbiol Infect
. 2016 Jun;
22(8):711-4.
PMID: 27297319
Mycoplasma pneumoniae is a leading cause of respiratory disease. In the Intensive Care Unit (ICU) setting M. pneumoniae is not considered a common pathogen. In 2010-13 an epidemic of M. ...
4.
Cohen M, Block C, Moses A, Nir-Paz R
Clin Microbiol Infect
. 2013 Oct;
20(3):O188-96.
PMID: 24102767
The role of antibiotic exposure in the evolution and emergence of resistance is challenging to assess. We used carbapenem-resistant Pseudomonas aeruginosa (PA) phenotypes to assess possible factors that are associated...
5.
Nir-Paz R, Abutbul A, Moses A, Block C, Hidalgo-Grass C
Euro Surveill
. 2012 Mar;
17(8).
PMID: 22401504
A substantial epidemic of Mycoplasma pneumonia infection was reported in late 2011 in some European countries. We report here an epidemic of M. pneumonia infection that began in Jerusalem during...
6.
Nir-Paz R, Korenman Z, Ron M, Michael-Gayego A, Cohen-Poradosu R, Valinsky L, et al.
Epidemiol Infect
. 2009 Jun;
138(1):53-60.
PMID: 19480723
Streptococcus pyogenes group A (GAS) is a primary human pathogen. We performed genetic emm sequence and serological T-antigen typing of 819 mostly invasive GAS isolates recovered in Israel during 1996-2005....
7.
Berkun Y, Nir-Paz R, Ami A, Klar A, Deutsch E, Hurvitz H
Arch Dis Child
. 2008 Mar;
93(8):690-4.
PMID: 18337275
Objective: To assess the clinical and laboratory features of acute otitis media (AOM) in infants younger than 2 months, to look for factors predicting bacterial otitis, and to evaluate the...
8.
Nir-Paz R, Michael-Gayego A, Ron M, Block C
Clin Microbiol Infect
. 2006 Jun;
12(7):685-8.
PMID: 16774570
Eight commercially available tests for Mycoplasma pneumoniae (Serodia-Myco II, Labsystems IgM and IgG EIA, IgM and IgG LISA tests, ImmunoWell IgG test and SeroMP IgM and IgG) were compared using...
9.
Greenbaum E, Nir-Paz R, Linton D, Ben-Hur T, Meirovitz A, Zakay-Rones Z
J Clin Virol
. 2003 Dec;
29(1):23-6.
PMID: 14675865
Background: Influenza is an important cause of morbidity and mortality in immunocompromised hosts. Recommendations exists for vaccination each year, yet disease can still occur. Objectives: To describe the course of...
10.
Nir-Paz R, Gross A, Chajek-Shaul T
Ann Rheum Dis
. 2002 Aug;
61(9):832-3.
PMID: 12176811
Objective: To study the prevalence and the clinical characterisation of jaw problems in patients with giant cell arteritis (GCA). Methods: the prevalence of such symptoms in patients with GCA was...